Do Surrogate Endpoints Better Correlate with Overall Survival in Studies That Did Not Allow for Crossover or Reported Balanced Postprogression Treatments? An Application in Advanced Non–Small Cell Lung Cancer

Autor: Hashim, Mahmoud, Pfeiffer, Boris M., Bartsch, Robert, Postma, Maarten, Heeg, Bart
Zdroj: In Value in Health January 2018 21(1):9-17
Databáze: ScienceDirect